Febrile neutropenia in cancer patients in a tertiary care medical center in Lebanon: Microbial spectrum and outcome

Journal Medical Libanais

Volumn 48, Issue 3, 2000, Pages 136-142

  Hamzeh, F ^a   Kanj, S S ^a   Uwaydah, M ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CEFTAZIDIME; FLUCONAZOLE; METICILLIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; CANCER PATIENT; FEBRILE NEUTROPENIA; GRAM NEGATIVE SEPSIS; GRAM POSITIVE BACTERIUM; LEUKEMIA; LYMPHOMA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIPLE MYELOMA; MYCOSIS; PSEUDOMONAS AERUGINOSA; SOLID TUMOR; URINARY TRACT INFECTION;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGED; BACTERIAL INFECTIONS; CROSS INFECTION; FEMALE; FEVER; HOSPITAL MORTALITY; HUMANS; INFECTION CONTROL; LEBANON; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0033637576     PISSN: 00239852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Management of fever in patients with cancer and treatment-induced neutropenia
2. Empirical antibiotic therapy for fever in neutropenic patients
3. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
4. Antibiotic treatment of febrile episodes in neutropenic cancer patients: Clinical and economic considerations
5. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia
6. Empiric antibiotic therapy for granulocytopenic cancer patients
7. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis
8. Febrile neutropenia
9. Gram-positive bacteremia in granulocytopenic cancer patients
10. Septicaemia in febrile neutropenic children with cancer in Saudi Arabia
11. Ceftazidime and amikacin as empiric treatment of febrile episodes in neutropenic patients in Saudi Arabia
12. Febrile neutropenia in cancer patients in Kuwait: Microbial spectrum and outcome
13. Infections chez les cancereux granulocytopeniques. Etude retrospectives de 59 episodes febriles hospitalises
14. Febrile episodes in children with cancer in the United Arab Emirates
15. Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipients. A 5-year prospective study
16. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia
17. A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infection in cancer patients
18. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia
19. Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer; a multicenter randomized trial
20. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient
21. Betalactam antibiotic therapy in febrile granulocytopenic patients: A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone
22. A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients
23. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients
24. Piperacillin/tazobactam versus cefepime as initial empirical antimicrobial therapy in febrile neutropenic patients: A prospective randomized pilot study
25. Monitoring antibiotic usage and bacterial susceptibility patterns: A decade of experience with ceftazidime
26. Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: A randomized prospective study
27. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients
28. Antifungal susceptibility of candida isolates at the American University of Beirut Medical Center